From: The metabolic syndrome and progression of carotid atherosclerosis over 13 years. The Tromsø study
Follow-up levels | Change from baseline to follow-up | |||||||
---|---|---|---|---|---|---|---|---|
IMT (mm) | TPA†(mm²) | ΔIMT (mm) | ΔTPA†(mm²) | |||||
β | p‡ | β | p‡ | β | p‡ | β | p‡ | |
Men | ||||||||
Age | 0.008 | <0.0001 | 0.102 | <0.0001 | - | - | 0.031 | <0.0001 |
Components of MetS | ||||||||
Hypertension | 0.045 | 0.0004 | 0.642 | 0.0003 | - | - | - | - |
Abdominal obesity | - | - | - | - | - | - | - | - |
Hypertriglyceridemia | 0.029 | 0.01 | - | - | - | - | - | - |
Low HDL-level | - | - | - | - | - | - | - | - |
Impaired glucose tolerance | 0.102 | 0.001 | 1.129 | 0.01 | 0.075 | 0.006 | - | - |
LDL cholesterol | 0.013 | 0.02 | 0.263 | 0.0006 | - | - | - | - |
Daily smoking | 0.04 | 0.0001 | 1.134 | <0.0001 | 0.021 | 0.006 | 0.516 | 0.001 |
Women | ||||||||
Age | 0.008 | <0.0001 | 0.073 | <0.0001 | 0.002 | <0.0001 | 0.027 | <0.0001 |
Components of MetS | ||||||||
Hypertension | 0.041 | <0.0001 | 0.643 | <0.0001 | - | - | 0.308 | 0.02 |
Abdominal obesity | - | - | - | - | - | - | - | - |
Hypertriglyceridemia | 0.026 | 0.014 | - | - | - | - | - | - |
Low HDL-level | 0.031 | 0.012 | - | - | - | - | - | - |
Impaired glucose tolerance | - | - | - | - | - | - | - | - |
LDL cholesterol | 0.021 | <0.0001 | 0.425 | <0.0001 | - | - | 0.195 | 0.0004 |
Daily smoking | 0.025 | 0.025 | 0.956 | <0.0001 | 0.034 | 0.0008 | 0.537 | <0.0001 |